Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Other material event · Item 5.07
Centessa Pharmaceuticals plc
7
Other material event
Jun 12, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Other material event · Item 5.07 |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Centessa Pharmaceuticals plc filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. Employer Identification Number) Mailing address: 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom (Address of principal executive offices) (Zip code) Registrant’s telephone number, including area code: +1 ( 617 ) 468-5770 Former name or address, if changed since last report: Check the appropriate box below if the Form 8-K filing is intende… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 12, 2026 |
| Accession number | 0001193125-26-269474 |
| Reported items | Item 5.07, Other events the company considers material See Analysis tab for workforce implications |
